Completed PHASE3 INTERVENTIONAL 2-arm NCT01347853

Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain

A Phase 3, Double-blind, Randomized Study of the Safety, Tolerability, and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain

Sponsor: Egalet Ltd

Conditions Postoperative Pain

Interventions Ketorolac tromethamine Placebo

Updated 6 times since 2017 Last updated: Feb 6, 2017 Started: Jun 30, 2003 Primary completion: Jun 30, 2005 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Postoperative Pain, this trial is completed. The trial is conducted by Egalet Ltd and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Egalet Ltd

Data source: Egalet Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, New Zealand